Exploring the efficacy and safety of topical Jaungo application in patients with atopic dermatitis: A pilot randomized, double-blind, placebo-controlled study
- 1 October 2018
- journal article
- research article
- Published by Elsevier in Complementary Therapies in Medicine
- Vol. 40, 22-28
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Health and Welfare
- Korea Health Industry Development Institute (HI12C1889, HI13C0530)
- Traditional Korean Medicine R&D Program
This publication has 18 references indexed in Scilit:
- A (S)-(+)-decursin derivative, (S)-(+)-3-(3,4-dihydroxy-phenyl)-acrylic acid 2,2-dimethyl-8-oxo-3,4-dihydro-2H,8H-pyrano[3,2-g]-chromen-3-yl-ester, attenuates the development of atopic dermatitis-like lesions in NC/Nga miceMolecular Biology Reports, 2013
- Balancing efficacy and safety in the management of atopic dermatitis: the role of methylprednisolone aceponateJournal of the European Academy of Dermatology and Venereology, 2011
- Skin application of urea‐containing cream affected cutaneous arterial sympathetic nerve activity, blood flow, and water evaporationSkin Research and Technology, 2011
- Complementary and Alternative Interventions in Atopic DermatitisImmunology and Allergy Clinics of North America, 2010
- Possible Pathogenic Role of Th17 Cells for Atopic DermatitisJournal of Investigative Dermatology, 2008
- The safety of tacrolimus ointment for the treatment of atopic dermatitis: a reviewBritish Journal of Dermatology, 2007
- Approaches for optimizing the calibration standard of Tewameter TM 300Experimental Dermatology, 2006
- Shiunko Promotes Epithelization of Wounded SkinThe American Journal of Chinese Medicine, 2004
- Atopic dermatitisThe Lancet, 2003
- The eczema area and severity index (EASI): assessment of reliability in atopic dermatitisExperimental Dermatology, 2001